The Journal of Infection in Developing Countries This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Characterization of carbapenemase-producing Gram-negative bacilli: first report of blaNDM-1 in Enterobacter cloacae
Conclusions: In this study, we report the first incidence ofblaNDM-1 gene inEnterobacter cloacae isolated from urine sample in Algeria. (Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: Manel Debabza, Raoudha Dziri, Abdelbasset Mechai, Amel Bouguessa, Naouel Klibi, Hadda Imene Ouzari Source Type: research

ChatGPT: ethical concerns and challenges in academics and research
Conclusions: Regulations for ethical and privacy concerns related to the use of ChatGPT in academics and research need to be developed. (Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: Ankita Guleria, Kewal Krishan, Vishal Sharma, Tanuj Kanchan Source Type: research

Testicular involvement of Brucellosis: A 10-year, multicentre study
Conclusions: Although epididymo-orchitis was the most frequently determined form of involvement in this study, there was also seen to be a significant number of patients presenting with epididymitis. Male patients presented with the clinical status of brucellosis should be questioned about swelling and pain in the testes to avoid overlooking testicular involvement. (Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: Mehmet Celik, Fethiye Akgul, Sevil Alkan, Deniz Alt ındag, Fatih Esmer, Ahmet Sahin, Davut Ipek, Yeliz Cicek, Esra Gurbuz, Mehmet Resat Ceylan, Nevin Guler Dincer Source Type: research

Evaluation of risk factors for the development of bacteremia and complications in patients with brucellosis: Is it possible to predict the clinical course?
Conclusions: The risk of clinical progression and complications could be predicted with symptoms and signs such as myalgia, low back pain, weakness/fatigue, weight loss, splenomegaly, and easily accessible laboratory parameters such as serum STAT/BCGT titer and platelet level. (Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: Tuba Kuruoglu, Levent Sensoy, Aynur Atilla, Fatih Temocin, Demet Gur, Esra Tanyel Source Type: research

Factors contributing to antibiotic use among children younger than five years old with fever, acute respiratory illness, and diarrhea in Bangladesh
Conclusions: Overall, one-third of the under-five children in Bangladesh consumed antibiotics to treat infectious diseases. Multiple factors contribute to the prevalence of antibiotic use. The results highlight the need to regulate antibiotic use and prioritize national intervention programs. (Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: Probir Kumar Ghosh, Kaniz Khatun E Jannat, Ausraful Islam, Ireen Sultana Shanta, Kazi Munisul Islam, Md. Golam Dostogir Harun Source Type: research

Syndromic testing for increasing diagnostic accuracy in gastrointestinal infection
Conclusions: Syndromic testing can increase the etiologic diagnosis of gastrointestinal infections in a shorter time period than the conventional methods. (Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: Ade Dharmawan, Pusparini Source Type: research

Cerebral cystic echinococcosis reactivation during therapy for squamous tumor of the cervix: possible interactions?
(Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: Tommaso Lupia, Valentina Fornari, Alberto Gaviraghi, Francesco Giuseppe De Rosa Source Type: research

Fragile states and the politics of pandemic management
(Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: Saverio Bellizzi, Giuseppe Pichierri, Catello M Panu Napodano, Osama Ali Maher Source Type: research

Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India
Conclusions: The risk of COVID-19 varied among the high-risk groups of Odisha. Periodic seroprevalence studies in future are essential to protect the high-risk personnel involved in frontline activities during the pandemic. (Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: Srikanta Kanungo, Sidhartha Giri, Debdutta Bhattacharya, Jaya Singh Kshatri, Subrata Kumar Palo, Debaprasad Parai, Jyotirmayee Turuk, Ira Praharaj, Asit Mansingh, Girish Chandra Dash, Hari Ram Choudhary, Matrujyoti Pattnaik, Shakti Ranjan Barik, Amiya Ran Source Type: research

COVID-19 infection among healthcare workers in an oncology hospital
Conclusions: During the study period, half of the healthcare workers in our hospital developed COVID-19 infection of whom 9.5% re-infected, predominantly during the Omicron variant period. Our findings highlight the importance of taking preventive measures and administering booster vaccine doses even after initial vaccination/infection. (Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: G ülşen İskender, Duygu Mert, Zühal Avşar, Servet Kölgelier, Mustafa Ertek Source Type: research

Liver damage and hepatomegaly in COVID-19 patients
Conclusions: Patients who need to be hospitalized with COVID-19 and who do not have acute and/or chronic liver disease, elevated liver function test results, and an increase in liver sizes at presentation, it was seen that these did not have an effect on the clinical outcome. However, in addition to the presence of advanced age and comorbidity, the presence of hepatomegaly measured by CT at admission, and high LDH and CK levels were associated with poor clinical outcomes. (Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: P ınar Yürük Atasoy, Engin Beydoğan Source Type: research

Finegoldia magna and Mucorales molds co-infection in a severe case of SARS-CoV-2 disease
Conclusions: Careful multidisciplinary follow-up of patients treated for severe SARS-CoV-2 disease is necessary for the timely diagnosis of complications such as uncontrolled diabetes mellitus and opportunistic infections. (Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: Rozaliya Hristova, Alexandrina Vlahova, Maria Christova, Konstantin Stamatov, Pavel Stanimirov Source Type: research

A survey of perceived risk and protective behaviours towards COVID-19 in 2020 in Iraqi Kurdistan
Conclusions: Understanding the general public ’s risk perception toward the COVID-19 infection is essential for determining effective protective measures and can be used to guide proper preventive behaviour. (Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: Karwan M-Amen, Sherzad A Shabu, Kazhan I Mahmood, Nazar P Shabila Source Type: research

Post-COVID condition: a survey of patients recovered from COVID-19 in Central Vietnam
Conclusions: The post-COVID condition can persist for several weeks or months, but will mostly be in remission after 6 months, and completely resolve after 9 months from the onset of the infection. (Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: Toan Khanh Tran, Son Nguyen Truong, Loan Tran Thanh, Ngoc Le Hoang Gia, Hieu Pham Trung, Binh Tran Dinh Source Type: research

Comparative study of TNF- α and IL-10 levels at different times of the course of COVID-19
Conclusions: The uncontrolled immune response to SARS-CoV-2 in the second week of the disease can be the result of dysregulated production of endogenous anti-inflammatory cytokines. This leads to a severe disease course and a possible unfavorable outcome. (Source: The Journal of Infection in Developing Countries)
Source: The Journal of Infection in Developing Countries - September 29, 2023 Category: Infectious Diseases Authors: Arshak Ghazaryan, Vigen Asoyan, Alvard Hovhannisyan, Melanya Kozmoyan, Arevhat Karapetyan, Armine Minasyan, Naira Gyulazyan Source Type: research